Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.

Wahn U, Bos JD, Goodfield M, Caputo R, Papp K, Manjra A, Dobozy A, Paul C, Molloy S, Hultsch T, Graeber M, Cherill R, de Prost Y; Flare Reduction in Eczema with Elidel (Children) Multicenter Investigator Study Group.

Pediatrics. 2002 Jul;110(1 Pt 1):e2.

PMID:
12093983
[PubMed - indexed for MEDLINE]
2.

Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug.

Kapp A, Papp K, Bingham A, Fölster-Holst R, Ortonne JP, Potter PC, Gulliver W, Paul C, Molloy S, Barbier N, Thurston M, de Prost Y; Flare Reduction in Eczema with Elidel (infants) multicenter investigator study group.

J Allergy Clin Immunol. 2002 Aug;110(2):277-84.

PMID:
12170269
[PubMed - indexed for MEDLINE]
3.

Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants.

Ho VC, Gupta A, Kaufmann R, Todd G, Vanaclocha F, Takaoka R, Fölster-Holst R, Potter P, Marshall K, Thurston M, Bush C, Cherill R.

J Pediatr. 2003 Feb;142(2):155-62.

PMID:
12584537
[PubMed - indexed for MEDLINE]
4.

Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study.

Meurer M, Fölster-Holst R, Wozel G, Weidinger G, Jünger M, Bräutigam M; CASM-DE-01 study group.

Dermatology. 2002;205(3):271-7.

PMID:
12399676
[PubMed - indexed for MEDLINE]
5.

Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.

Gollnick H, Kaufmann R, Stough D, Heikkila H, Andriano K, Grinienko A, Jimenez P; Pimecrolimus Cream 1% in (adult) Eczema: Prevention of Progression Multicentre Investigator Study Group.

Br J Dermatol. 2008 May;158(5):1083-93. doi: 10.1111/j.1365-2133.2008.08484.x. Epub 2008 Mar 13.

PMID:
18341665
[PubMed - indexed for MEDLINE]
6.

Spotlight on topical pimecrolimus in atopic dermatitis.

Wellington K, Jarvis B.

Am J Clin Dermatol. 2002;3(6):435-8. Review.

PMID:
12113651
[PubMed - indexed for MEDLINE]
7.

Treatment of infants with atopic eczema with pimecrolimus cream 1% improves parents' quality of life: a multicenter, randomized trial.

Staab D, Kaufmann R, Bräutigam M, Wahn U; CASM981CDE04-Study Group.

Pediatr Allergy Immunol. 2005 Sep;16(6):527-33.

PMID:
16176401
[PubMed - indexed for MEDLINE]
8.

Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis.

Frankel A, Sohn A, Patel RV, Lebwohl M.

J Drugs Dermatol. 2011 Jun;10(6):666-72.

PMID:
21637908
[PubMed - indexed for MEDLINE]
9.

Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.

Wellington K, Jarvis B.

Drugs. 2002;62(5):817-40. Review.

PMID:
11929333
[PubMed - indexed for MEDLINE]
10.

Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.

McKenna SP, Whalley D, de Prost Y, Staab D, Huels J, Paul CF, van Assche D.

J Eur Acad Dermatol Venereol. 2006 Mar;20(3):248-54.

PMID:
16503881
[PubMed - indexed for MEDLINE]
11.

Use of pimecrolimus cream 1% (Elidel) in the treatment of atopic dermatitis in infants and children: the effects of ethnic origin and baseline disease severity on treatment outcome.

Eichenfield LF, Lucky AW, Langley RG, Lynde C, Kaufmann R, Todd G, Lindsley L, Barbier N, Felser JM.

Int J Dermatol. 2005 Jan;44(1):70-5.

PMID:
15663667
[PubMed - indexed for MEDLINE]
12.

Effect of pimecrolimus cream 1% on the long-term course of pediatric atopic dermatitis.

Papp K, Staab D, Harper J, Potter P, Puig L, Ortonne JP, Molloy S, Barbier N, Paul C; Multicentre Investigator Study Group.

Int J Dermatol. 2004 Dec;43(12):978-83.

PMID:
15569038
[PubMed - indexed for MEDLINE]
13.

Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitis.

Langley RG, Eichenfield LF, Lucky AW, Boguniewicz M, Barbier N, Cherill R.

Pediatr Dermatol. 2008 May-Jun;25(3):301-7. doi: 10.1111/j.1525-1470.2008.00671.x.

PMID:
18577032
[PubMed - indexed for MEDLINE]
14.

Pimecrolimus cream 1%: a new development in nonsteroid topical treatment of inflammatory skin diseases.

Hebert AA, Warken KA, Cherill R.

Semin Cutan Med Surg. 2001 Dec;20(4):260-7. Review.

PMID:
11770913
[PubMed - indexed for MEDLINE]
15.

Pimecrolimus: a review of pre-clinical and clinical data.

Graham-Brown RA, Grassberger M.

Int J Clin Pract. 2003 May;57(4):319-27. Review.

PMID:
12800465
[PubMed - indexed for MEDLINE]
16.

Safety and efficacy of early intervention with pimecrolimus cream 1% combined with corticosteroids for major flares in infants and children with atopic dermatitis.

Siegfried E, Korman N, Molina C, Kianifard F, Abrams K.

J Dermatolog Treat. 2006;17(3):143-50. Erratum in: J Dermatolog Treat. 2006;17(4):256.

PMID:
16854753
[PubMed - indexed for MEDLINE]
17.

Effectiveness and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis.

Sigurgeirsson B, Ho V, Ferrándiz C, Andriano K, Grinienko A, Jimenez P; Pimecrolimus 1% cream in (paediatric) Eczema: Prevention of Progression multi-centre investigator study group.

J Eur Acad Dermatol Venereol. 2008 Nov;22(11):1290-301. doi: 10.1111/j.1468-3083.2008.02785.x. Epub 2008 Jul 24.

PMID:
18624866
[PubMed - indexed for MEDLINE]
18.

A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.

Murrell DF, Calvieri S, Ortonne JP, Ho VC, Weise-Riccardi S, Barbier N, Paul CF.

Br J Dermatol. 2007 Nov;157(5):954-9.

PMID:
17935515
[PubMed - indexed for MEDLINE]
19.

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.

Eichenfield LF, Lucky AW, Boguniewicz M, Langley RG, Cherill R, Marshall K, Bush C, Graeber M.

J Am Acad Dermatol. 2002 Apr;46(4):495-504.

PMID:
11907497
[PubMed - indexed for MEDLINE]
20.

SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis.

Luger T, Van Leent EJ, Graeber M, Hedgecock S, Thurston M, Kandra A, Berth-Jones J, Bjerke J, Christophers E, Knop J, Knulst AC, Morren M, Morris A, Reitamo S, Roed-Petersen J, Schoepf E, Thestrup-Pedersen K, Van Der Valk PG, Bos JD.

Br J Dermatol. 2001 Apr;144(4):788-94.

PMID:
11298538
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk